Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background There is debate about how best to measure patient reported outcomes (PROs) in irritable bowel syndrome (IBS). We pooled data from clinical trials to measure the psychometric properties of IBS endpoints, including binary responses (e.g. “adequate relief”) and 50% improvement in symptom severity. Methods We pooled patient-level data from 12 IBS drug trials involving 10,066 participants. We tested the properties of binary response and 50% improvement endpoints, including the impact of baseline severity on performance, and measured construct validity using clinical anchors. We calculated confidence intervals for the psychometric parameters of each endpoint, and compared estimates side-by-side between PROs. Results There were 9044 evaluable subjects (age=44; 85% F; 58% IBS-C; 31% IBS-D). Using the binary endpoint, the proportion responding in the mild, moderate, and severe groups was 42%, 40%, and 38%, respectively (p=0.0008). There was no effect of baseline severity on binary response (OR=0.99; CI=0.99–1.0; p=0.07). The proportions reaching 50% improvement in pain were 45%, 41%, and 41% respectively; there was a small, yet significant, impact of baseline severity (OR=1.04; CI=1.03–1.05; p<0.0001) that did not meet criteria for clinical relevance. Both endpoints revealed strong construct validity, and detected “minimally clinically important differences” (0.5 SD) in bowel symptoms. Both endpoints provided better discriminant spread in IBS-D than IBS-C subgroups. Conclusions Both the traditional binary and 50% improvement endpoints are equivalent in their psychometric properties. Neither is impacted by baseline severity, and both demonstrate excellent construct validity. They are optimized for the IBS-D population, but also appear valid in IBS-C.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003) · Medical Care · doi:10.1097/01.mlr.0000062554.74615.4c · Cited by 4,700
FRANCIS, C. Y., MORRIS, J., & WHORWELL, P. J. (1997) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1997.142318000.x · Cited by 1,708
Statistical Power Analysis for the Behavioral Sciences
Wassertheil, S., & Cohen, J. (1970) · Biometrics · doi:10.2307/2529115 · Cited by 1,383
Design of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.010 · Cited by 550
Self-citationDesign of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Whitehead, W. E., Chey, W. D., Matsueda, K., Shaw, M., Talley, N. J., & Veldhuyzen van Zanten, S. J. O. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.058 · Cited by 286
Self-citationLabus, J. S., Mayer, E. A., Chang, L., Bolus, R., & Naliboff, B. D. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31802e2f24 · Cited by 257
Self-citationLackner, J. M., Jaccard, J., Krasner, S. S., Katz, L. A., Gudleski, G. D., & Holroyd, K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.03.004 · Cited by 176
Cited by
Rome IV—Functional GI Disorders: Disorders of Gut-Brain Interaction
Drossman, D. A., & Hasler, W. L. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.03.035 · Cited by 1,928
Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation
Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036
Self-citationDesign of Treatment Trials for Functional Gastrointestinal Disorders
Irvine, E. J., Tack, J., Crowell, M. D., Gwee, K. A., Ke, M., Schmulson, M. J., Whitehead, W. E., & Spiegel, B. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.010 · Cited by 550
Self-citationMcKenzie, Y. A., Bowyer, R. K., Leach, H., Gulia, P., Horobin, J., O'Sullivan, N. A., Pettitt, C., Reeves, L. B., Seamark, L., Williams, M., et al. (2016) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12385 · Cited by 353
The role of mast cells in functional GI disorders
Wouters, M. M., Vicario, M., & Santos, J. (2016) · Gut · doi:10.1136/gutjnl-2015-309151 · Cited by 308
Metadata
- Authors
- Spiegel, B., Camilleri, M., Bolus, R., Andresen, V., Chey, W. D., Fehnel, S., Mangel, A., Talley, N. J., & Whitehead, W. E.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-12
- Volume
- 137
- Issue
- 6
- Pages
- 1944-1953.e3
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2159096930
- Cited by
- 75
- References
- 7
- FWCI
- 5.86
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report. https://app.cochat.ai/papers/10.1053/j.gastro.2009.08.047
- The paper
- Spiegel, B., Camilleri, M., Bolus, R., Andresen, V., Chey, W. D., Fehnel, S., Mangel, A., Talley, N. J., & Whitehead, W. E. (2009). Psychometric Evaluation of Patient-Reported Outcomes in Irritable Bowel Syndrome Randomized Controlled Trials: A Rome Foundation Report. Gastroenterology. https://doi.org/10.1053/j.gastro.2009.08.047
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.